1048 related articles for article (PubMed ID: 25528115)
1. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
James KD; Forester SC; Lambert JD
Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115
[TBL] [Abstract][Full Text] [Related]
2. Green tea polyphenol (-)-epigallocatechin-3-gallate triggered hepatotoxicity in mice: responses of major antioxidant enzymes and the Nrf2 rescue pathway.
Wang D; Wang Y; Wan X; Yang CS; Zhang J
Toxicol Appl Pharmacol; 2015 Feb; 283(1):65-74. PubMed ID: 25585349
[TBL] [Abstract][Full Text] [Related]
3. Potential role of the mitochondria as a target for the hepatotoxic effects of (-)-epigallocatechin-3-gallate in mice.
James KD; Kennett MJ; Lambert JD
Food Chem Toxicol; 2018 Jan; 111():302-309. PubMed ID: 29175576
[TBL] [Abstract][Full Text] [Related]
4. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice.
Lambert JD; Kennett MJ; Sang S; Reuhl KR; Ju J; Yang CS
Food Chem Toxicol; 2010 Jan; 48(1):409-16. PubMed ID: 19883714
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
Chow HH; Cai Y; Hakim IA; Crowell JA; Shahi F; Brooks CA; Dorr RT; Hara Y; Alberts DS
Clin Cancer Res; 2003 Aug; 9(9):3312-9. PubMed ID: 12960117
[TBL] [Abstract][Full Text] [Related]
6. High doses of (-)-epigallocatechin-3-gallate from green tea induces cardiac fibrosis in mice.
Cai Y; He SQ; Hong HQ; Cai YP; Zhao L; Zhang M
Biotechnol Lett; 2015 Dec; 37(12):2371-7. PubMed ID: 26272391
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice.
Church RJ; Gatti DM; Urban TJ; Long N; Yang X; Shi Q; Eaddy JS; Mosedale M; Ballard S; Churchill GA; Navarro V; Watkins PB; Threadgill DW; Harrill AH
Food Chem Toxicol; 2015 Feb; 76():19-26. PubMed ID: 25446466
[TBL] [Abstract][Full Text] [Related]
8. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
[TBL] [Abstract][Full Text] [Related]
9. Green tea epigallocatechin gallate binds to and inhibits respiratory complexes in swelling but not normal rat hepatic mitochondria.
Weng Z; Zhou P; Salminen WF; Yang X; Harrill AH; Cao Z; Mattes WB; Mendrick DL; Shi Q
Biochem Biophys Res Commun; 2014 Jan; 443(3):1097-104. PubMed ID: 24384371
[TBL] [Abstract][Full Text] [Related]
10. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
[TBL] [Abstract][Full Text] [Related]
11. Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice.
Lambert JD; Kim DH; Zheng R; Yang CS
J Pharm Pharmacol; 2006 May; 58(5):599-604. PubMed ID: 16640828
[TBL] [Abstract][Full Text] [Related]
12. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
13. Green tea polyphenol epigallocatechin-3-gallate alleviates nonalcoholic fatty liver disease and ameliorates intestinal immunity in mice fed a high-fat diet.
Huang J; Li W; Liao W; Hao Q; Tang D; Wang D; Wang Y; Ge G
Food Funct; 2020 Nov; 11(11):9924-9935. PubMed ID: 33095225
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-Gallate Reduces Hepatic Oxidative Stress and Lowers CYP-Mediated Bioactivation and Toxicity of Acetaminophen in Rats.
Yao HT; Li CC; Chang CH
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31405142
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of epigallocatechin gallate from green tea on oxidation and tissue incorporation of dietary lipids in mice fed a high-fat diet.
Friedrich M; Petzke KJ; Raederstorff D; Wolfram S; Klaus S
Int J Obes (Lond); 2012 May; 36(5):735-43. PubMed ID: 21750518
[TBL] [Abstract][Full Text] [Related]
16. Curcumin as a permeability enhancer enhanced the antihyperlipidemic activity of dietary green tea extract.
Pandit AP; Joshi SR; Dalal PS; Patole VC
BMC Complement Altern Med; 2019 Jun; 19(1):129. PubMed ID: 31196040
[TBL] [Abstract][Full Text] [Related]
17. Absorption, tissue distribution and elimination of 4-[(3)h]-epigallocatechin gallate in beagle dogs.
Swezey RR; Aldridge DE; LeValley SE; Crowell JA; Hara Y; Green CE
Int J Toxicol; 2003; 22(3):187-93. PubMed ID: 12851151
[TBL] [Abstract][Full Text] [Related]
18. Dietary Copper Reduces the Hepatotoxicity of (-)-Epigallocatechin-3-Gallate in Mice.
Kaleri NA; Sun K; Wang L; Li J; Zhang W; Chen X; Li X
Molecules; 2017 Dec; 23(1):. PubMed ID: 29295524
[TBL] [Abstract][Full Text] [Related]
19. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts.
Oketch-Rabah HA; Roe AL; Rider CV; Bonkovsky HL; Giancaspro GI; Navarro V; Paine MF; Betz JM; Marles RJ; Casper S; Gurley B; Jordan SA; He K; Kapoor MP; Rao TP; Sherker AH; Fontana RJ; Rossi S; Vuppalanchi R; Seeff LB; Stolz A; Ahmad J; Koh C; Serrano J; Low Dog T; Ko R
Toxicol Rep; 2020; 7():386-402. PubMed ID: 32140423
[TBL] [Abstract][Full Text] [Related]
20. Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup
Gu Y; Moroy G; Paul JL; Rebillat AS; Dierssen M; de la Torre R; Cieuta-Walti C; Dairou J; Janel N
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
